title: Role of clindamycin in the treatment of acute toxoplasmosis of the central nervous system.
abstract: Cerebral toxoplasmosis related to AIDS was treated with a combination regimen of pyrimethamine, clindamycin, and spiramycin, and in a second trial with a combination of pyrimethamine and clindamycin. Both regimens proved to be equally effective. The experience with the second trial shows that spiramycin does not provide additional benefit. Myelosuppressive side-effects due to pyrimethamine were prevented in most cases by addition of folinic acid to the regimen at the start of the antitoxoplasmic therapy. These data suggest that the combination of pyrimethamine and clindamycin is an effective alternative to the commonly used regimen consisting of pyrimethamine and sulfonamides.
authors.affiliation: Department of Internal Medicine, Rudolf Virchow University Hospital (Wedding), Freie Universität Berlin, FRG.
authors.forename: B
authors.initials: B
authors.lastname: Ruf
authors.forename: H D
authors.initials: HD
authors.lastname: Pohle
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000208:Acute Disease; D001927:Brain Diseases / Q000150:complications / Q000188:drug therapy*; D002981:Clindamycin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D006801:Humans; D002955:Leucovorin / Q000494:pharmacology; D011739:Pyrimethamine / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D015572:Spiramycin / Q000627:therapeutic use*; D014123:Toxoplasmosis / Q000150:complications / Q000188:drug therapy*
chemical_list: D002981:Clindamycin; D015572:Spiramycin; D002955:Leucovorin; D011739:Pyrimethamine